美股新聞 標題聯播 · 近 24 小時 337 則 · 29 個來源 · 最新 9/20 04:53
本站只列標題、來源、時間與原文連結,不重製內文;著作權屬原媒體與原作者。新聞稿通路(PR Newswire、Business Wire、GlobeNewswire)是公司自己發的,屬第一手;媒體是轉述。
全部 · MRNA近 30 天 34 則 · 第 1 / 1 頁
- 道瓊期貨：市場漲勢能否起飛？Robinhood、Sandisk、超微、Moderna 飆升至買進區Dow Jones Futures: Can The Market Rally Take Flight? Robinhood, Sandisk, AMD, Moderna Surge Into Buy Areas
- 道瓊期貨:市場漲勢會起飛嗎?Robinhood、Sandisk、AMD、Moderna 衝進買進區Dow Jones Futures: Will The Market Rally Take Flight? Robinhood, Sandisk, AMD, Moderna Surge Into Buy Areas
- Moderna (MRNA) 下跌，最新關注焦點背後是什麼？Moderna (MRNA) Dropped, So What Is Behind The Latest Attention?
- BioCryst Eyes $1B Rare-Disease Future Through External Innovation
- Axsome Therapeutics vs. Moderna: Which Healthcare Stock Is a Better Buy in 2026?
- 一檔股票上漲 540%，而且不只它一檔One stock is up 540%, and it's not alone
- 道瓊期貨：標普 500、那斯達克反彈後，接下來呢？Moderna、超微、SpaceX 閃現買進訊號。Dow Jones Futures: After S&P 500, Nasdaq Rebound, What's Next? Moderna, AMD, SpaceX Flash Buy Signals.
- A Bear Market Is Coming -- We Just Don't Know When. Here's What History Says You Must Do to Get Through It Relatively Unscathed.
- Zacks Investment Ideas feature highlights: NVIDIA, Advanced Micro Devices, Tempus, Moderna, Super Micro Computer and Aya Gold & Silver
- BioNTech Threw in the Towel on Its Colorectal Cancer Vaccine Trial. Should Investors Be Worried?
- 為何 Moderna (MRNA) 股價今日大漲Why Are Moderna (MRNA) Shares Soaring Today
- 2026 年的悲觀氛圍會帶來機會嗎？Will 2026 Doom and Gloom Lead to Opportunity?
- Moderna：又一天 又一次股價大波動。癌症疫苗漲勢回來了嗎？Moderna: Another Day, Another Big Stock Move. Is the Cancer Vaccine Rally Back On?
- Moderna Climbs 6% as Cancer Vaccine Trade Extends a 137% Month; BioNTech and Novavax Edge Higher
- This Tiny Biotech Is Beating MRNA, IOVA And SLS — Here's How A Billionaire Fueled Its September Rally
- This Dividend Stock Is Beating the Market in 2026 and Yields 2.36%
- Is Cancer the Turnaround Moderna Has Been Looking for Post-COVID?
- AbbVie Maps Post-HUMIRA Growth With Apogee Deal, Immunology Pipeline
- Unpopular Stocks Walking a Fine Line
- Moderna (MRNA) Ascends While Market Falls: Some Facts to Note
- Eli Lilly Eyes Obesity Access Expansion With Zepbound, Foundayo and Pipeline Bets
- Moderna, 10x Genomics, Oscar Health, and Novavax Shares Are Soaring, What You Need To Know
- Amgen vs. Moderna: Which Healthcare Stock Is a Better Buy in 2026?
- This Fund Bought Moderna Before It Nearly Tripled. See Its 2 New Stock Picks
- Here Are Thursday’s Top Wall Street Analyst Research Calls: Broadcom, Deere & Company, Dell Technologies, Devon Energy, Moderna, Permian Resources, PG&E, Thermo Fisher, Viper Energy, and More
- Moderna upgraded, Allstate downgraded: Wall Street's top analyst calls
- Moderna raises $2.6B to support cancer work; FDA clears updated COVID vaccines
- Tempus AI (TEM) Jumped on Moderna’s Melanoma Win. Did its $1.5B Personalis Acquisition Just Get Validated?
- Moderna Stock Carries A Market Value Its Revenue Does Not Support
- KURA Stock Hits Fresh 52-Week High As CEO Buys More Shares — Retail Wonders If Wilson Is Following Moderna CEO’s Playbook
- Here Are Tuesday’s Top Wall Street Analyst Research Calls: Advanced Micro Devices, Dynatrace, Five Below, Fortune Brands, Klarna Group, Jersey Mike’s Subs, Moderna, Sherwin-Williams, and More
- Myriad Genetics and Moderna Shares Plummet, What You Need To Know
- Moderna Stock Had A Readout Waiting In Plain Sight
- SLS, IBRX Stocks In Focus: Analyst Says Moderna-Merck Cancer Vaccine Success ‘Bodes Well’ For Oncology
- Moderna And Merck's Cancer Vaccine: Are Investors Putting The Cart Before The Horse?
- Why Moderna Stock’s Historic Surge Is a Big Lesson for Markets
- Moderna’s Newfound War Chest Opens Door for 4 Strategic Acquisition Targets
- Moderna Could Be First S&P 500 Stock Since 2008 to Double in a Day
- TEM, BNTX, MRVI, RGEN, NVAX Stock Rallies As Moderna-Merck Cancer Vaccine Clears Late-stage Trial
- What It Means To Hold Moderna Stock In A Crash
中文標題是機器翻譯(NLLB 模型,不外送資料),專有名詞靠對照表,語意以英文原題為準。預設藏掉:選股文與自動生成站(Motley Fool、24/7 Wall St、Trefis、MarketBeat…)、加密幣、律師事務所的股東訴訟廣告、非英文、新聞稿裡的人事任命 / 出席活動 / 得獎、個人理財專欄,以及通路稿標題對不到上市公司的。個股標籤是從標題辨識的(通路標準寫法 (NASDAQ: NVDA)、公司名對照);帶「?」的是從摘要辨識、信心較低。來源等級 A / B / C 只影響精選排序,不是對媒體的評價。